NovaBridge Biosciences
NBP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,837 | -$13,268 | -$22,869 | -$66,144 |
| Dep. & Amort. | $216 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $2,149 | $2,178 | $11,321 |
| Change in WC | $7,008 | $0 | $0 | $0 |
| Other Non-Cash | $1,459 | $11,118 | $20,691 | $54,823 |
| Operating Cash Flow | $1,846 | $0 | $0 | $0 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | -$0 | $0 | $0 | $0 |
| Inv. Purchases | $24 | $0 | $0 | $0 |
| Inv. Sales/Matur. | -$75 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$51 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $61,836 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$968 | $0 | $0 | $0 |
| Financing Cash Flow | $60,868 | $0 | $0 | $0 |
| Forex Effect | -$7 | $0 | $0 | $0 |
| Net Chg. in Cash | $62,657 | $0 | $0 | $0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $165,407 | $0 | $0 | $0 |
| End Cash | $228,064 | $0 | $0 | $0 |
| Free Cash Flow | $1,846 | $0 | $0 | $0 |